Oct
28
2021
On demand

Considerations for developing scalable and efficient collection network processes

This webinar will focus on apheresis center best practices within the allogeneic product collection pathway that help build efficiencies within cell and gene therapy protocols. These best practices ultimately lead to high-quality, therapy-matched starting material for emerging cell and gene therapies.

Many crucial considerations impact a cell and gene therapy developer’s apheresis center selection strategy and ability to efficiently scale processes. Anytime collection processes or protocols differ from those in place at a center, there are likely implications for training, forms and standard operating procedures (SOPs), which can potentially delay a first collection.

Attend this webinar to learn how to avoid variability and maximize quality and scalability throughout the cell therapy supply chain – ultimately improving collections for product manufacturing. 

  • Common protocol decisions cell and gene therapy developers make along the product collection pathway that can impact ability to scale
  • Specific considerations for collecting starting material for allogeneic cell therapies
  • Factors for post-collection transport and processing to ensure efficient delivery of starting material to the manufacturer

Lacey Anderson

Senior Manager, Collection Network Management Be The Match BioTherapies
Lacey Anderson is the Senior Manager of Collection Network Management for Be The Match BioTherapies®. Lacey and her team work to develop and manage our Collection Network for cell and gene therapies in clinical trials, interfacing between our collection centers and cell and gene therapy developers.Lacey joined Be The Match BioTherapies in August 2019, bringing with her over 10 years of experience working in apheresis centers. She has held positions in center operations and quality management, as well as donor care supervision. Lacey holds Master of Science in Health Information Management with an emphasis in Compliance from The College of St. Scholastica, Duluth, Minn. She holds Master of Science in Biological Anthropology from North Dakota State University, Fargo.

Sara Butler

Network Liaison, Be The Match BioTherapies
Sara Butler is a Collection Network Liaison for Be The Match BioTherapies. She serves as a liaison between Be The Match BioTherapies stakeholders, clients and network centers. Sara also provides technical expertise and consultation to improve operational processes and Be The Match BioTherapies product quality. Sara brings to Be The Match BioTherapies nearly a decade of cell therapy experience and knowledge of the industry. She holds a Bachelor’s degree in Biological Sciences

Allison Montalvo

Program Manager, Oncology, Janssen ( A division of J&J)
Allison Montalvo is currently a Program Manager at Janssen ( A division of J&J) in Oncology. She has over 25 years’ experience in Biotech and Pharmaceutical Drug development (Merck, Teva, Tmunity and now Janssen). Prior to coming to Janssen, Allison was the Head of Project Management and Clinical Supplies at Tmunity. There, she led and developed integrated solutions for end to end supply chain management of CART trials. 

SPEAKERS

Lacey Anderson
Senior Manager, Collection Network Management, Be The Match BioTherapies
Sara Butler
Network Liaison, Be The Match BioTherapies
Allison Montalvo,
Program Manager, Oncology, Janssen ( A division of J&J)

You might also like

Strategic supply chain design: flexibility and scalability considerations for...

N Kulkarni, PhD
G Linton, RA, AIA, LEED AP BD+C
Niranjan Kulkarni, PhD
Niranjan Kulkarni, PhD
Senior Director, Consulting Services at CRB
Grace Linton, RA, AIA, LEED AP BD+C
Grace Linton, RA, AIA, LEED AP BD+C
Director of Process Architecture at CRB
28 April 2022
Watch now

Supply chain efficiency and sourcing for scaling your gene therapy operation

C Martin
D Young
Céline  Martin
Céline Martin
Senior Product Manager, Gene Therapy at Thermo Fisher Scientific
Don Young
Don Young
Senior Global Product Manager, Single-Use Technologies at Thermo Fisher Scientific
7 April 2022
Watch now

Rapid translation of a cellular therapeutic: Choosing product & process development...

A Patel
J Candiello
Ashish Patel
Ashish Patel
Clinical Senior Lecturer and Consultant Vascular and Endovascular Surgeon at Foundation for the National Institutes of Health
Joseph Candiello
Joseph Candiello
Senior Product Manager at RoosterBio Inc
10 March 2022
Watch now

Cell and gene therapy matures: Streamlining and smoothing the path to commercialization

M Hewitt
Matt Hewitt, PhD
Matt Hewitt, PhD
Senior Director, Scientific Services, Cell and Gene Therapy, Charles River Laboratories
11 January 2022
Watch now

Delivering an end-to-end industrialization roadmap for autologous cell therapy

M PhD,
J Garrity,
W Bagni
Matt Hewitt, PhD
Matt Hewitt, PhD
Senior Director, Scientific Services, Cell and Gene Therapy, Charles River Laboratories
Joe Garrity
Joe Garrity
Head of Autologous Cell Therapy Commercial Development, CGT, Lonza
Walter Bagni
Walter Bagni
Cell & Gene Technologies & Labelling CoE Lead, Lonza
6 July 2021
Watch now